MyFinsight
Home
Blog
About
Sequencing
$900M
(7.66%↑ Y/Y)
Microarray
$82M
(7.89%↑ Y/Y)
Sequencing
$154M
(13.24%↑ Y/Y)
Microarray
$23M
(109.09%↑ Y/Y)
Product
$982M
(7.68%↑ Y/Y)
Service
$177M
(20.41%↑ Y/Y)
Total revenue
$1,159M
(9.44%↑ Y/Y)
Gross profit
$770M
(10.79%↑ Y/Y)
Other income
(expense), net
$31M
(-71.03%↓ Y/Y)
Total cost of revenue
$389M
(6.87%↑ Y/Y)
Interest income
$8M
(-20.00%↓ Y/Y)
Income from operations
$245M
(14.49%↑ Y/Y)
Total other income
(expense), net
$15M
(-83.70%↓ Y/Y)
Total operating
expense
$525M
(9.15%↑ Y/Y)
Interest expense
$24M
(-4.00%↓ Y/Y)
Cost of
revenue-Product
$291M
(5.43%↑ Y/Y)
Cost of
revenue-Service
$80M
(12.68%↑ Y/Y)
Amortization of acquired
intangible assets
$18M
(5.88%↑ Y/Y)
Income before income
taxes
$260M
(-15.03%↓ Y/Y)
Selling, general and
administrative
$273M
(16.67%↑ Y/Y)
Research and development
$252M
(2.02%↑ Y/Y)
Net income
$207M
(-11.91%↓ Y/Y)
Provision for income taxes
$53M
(-25.35%↓ Y/Y)
Back
Back
Income Statement
ILLUMINA, INC. (ILMN)
ILLUMINA, INC. (ILMN)
source: myfinsight.com